Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Agile Therap (AGRX)

Agile Therap (AGRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 219,552
  • Shares Outstanding, K 69,810
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,610 K
  • 60-Month Beta 0.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.07
  • Low Estimate -0.10
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.44 +18.03%
on 02/27/20
4.77 -39.56%
on 02/12/20
-0.53 (-15.54%)
since 01/27/20
3-Month
1.90 +51.58%
on 12/12/19
4.77 -39.56%
on 02/12/20
+0.82 (+39.81%)
since 11/27/19
52-Week
0.35 +722.86%
on 10/29/19
4.77 -39.56%
on 02/12/20
+1.94 (+206.38%)
since 02/27/19

Most Recent Stories

More News
Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020

Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women's healthcare company, today announced that the Company will visit the Nasdaq MarketSite in Times Square on Wednesday, February 26, 2020....

AGRX : 2.91 (-7.32%)
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the pricing of its underwritten public offering of 15 million shares of its common stock at a public offering price...

AGRX : 2.91 (-7.32%)
Agile Therapeutics: 4Q Earnings Snapshot

PRINCETON, N.J. (AP) _ Agile Therapeutics Inc. (AGRX) on Thursday reported a loss of $6 million in its fourth quarter.

AGRX : 2.91 (-7.32%)
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All shares being...

AGRX : 2.91 (-7.32%)
Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

Current Cash and Cash Equivalents Expected to Meet Projected Operating Requirements through End of 2020

AGRX : 2.91 (-7.32%)
FDA Approves Agile Therapeutics, Inc.'s Twirla(R) (levonorgestrel and ethinyl estradiol) Transdermal System - A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin

Twirla is a new non-daily, non-invasive contraceptive approved in the U.S.

AGRX : 2.91 (-7.32%)
Agile Therapeutics, Inc. Enters into up to $35 Million Loan Facility with Perceptive Advisors

Funding to Support the Company's Commercialization Plans for Twirla

AGRX : 2.91 (-7.32%)
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences

AIRI : 1.30 (-3.70%)
DERM : 18.75 (+0.05%)
AGRX : 2.91 (-7.32%)
MBOT : 8.67 (-9.12%)
SAVA : 6.24 (-2.95%)
Buy Multibagger Stocks as Odds of a Rally Are High in 2020

Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.

AIRI : 1.30 (-3.70%)
DERM : 18.75 (+0.05%)
AGRX : 2.91 (-7.32%)
MBOT : 8.67 (-9.12%)
SAVA : 6.24 (-2.95%)
The Zacks Analyst Blog Highlights: Agile Therapeutics, Ares Capital, Cable One, Evolution Petroleum and Royal Gold

The Zacks Analyst Blog Highlights: Agile Therapeutics, Ares Capital, Cable One, Evolution Petroleum and Royal Gold

CABO : 1,569.26 (-1.92%)
ARCC : 17.80 (-1.00%)
AGRX : 2.91 (-7.32%)
RGLD : 103.94 (-3.04%)
EPM : 4.85 (+0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AGRX with:

Business Summary

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch...

See More

Key Turning Points

2nd Resistance Point 3.45
1st Resistance Point 3.30
Last Price 2.91
1st Support Level 3.00
2nd Support Level 2.86

See More

52-Week High 4.77
Fibonacci 61.8% 3.08
Last Price 2.91
Fibonacci 50% 2.56
Fibonacci 38.2% 2.04
52-Week Low 0.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar